Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies

Open access
Sinner, Moritz F., Stepas, Katherine A., Moser, Carlee B., Krijthe, Bouwe P., Aspelund, Thor, Sotoodehnia, Nona, Fontes, João D., Janssens, A. Cecile J.W., Kronmal, Richard A., Magnani, Jared W., Witteman, Jacqueline C., Chamberlain, Alanna M., Lubitz, Steven A., Schnabel, Renate B., Vasan, Ramachandran S., Wang, Thomas J., Agarwal, Sunil K., McManus, David D., Franco, Oscar H., Yin, Xiaoyan, Larson, Martin G., Burke, Gregory L., Launer, Lenore J., Hofman, Albert, Levy, Daniel, Gottdiener, John S., Kääb, Stefan, Couper, David, Harris, Tamara B., Astor, Brad C., Ballantyne, Christie M., Hoogeveen, Ron C., Arai, Andrew E., Soliman, Elsayed Z., Ellinor, Patrick T., Stricker, Bruno H.C., Gudnason, Vilmundur, Heckbert, Susan R., Pencina, Michael J., Benjamin, Emelia J., Alonso, Alvaro · 2014 · EP Europace

Abstract

AIMS: B-type natriuretic peptide (BNP) and C-reactive protein (CRP) predict atrial fibrillation (AF) risk. However, their risk stratification abilities in the broad community remain uncertain. We sought to improve risk stratification for AF using biomarker information. METHODS AND RESULTS: We ascertained AF incidence in 18 556 Whites and African Americans from the Atherosclerosis Risk in Communities Study (ARIC, n=10 675), Cardiovascular Health Study (CHS, n = 5043), and Framingham Heart Study (FHS, n = 2838), followed for 5 years (prediction horizon). We added BNP (ARIC/CHS: N-terminal pro-B-type natriuretic peptide; FHS: BNP), CRP, or both to a previously reported AF risk score, and assessed model calibration and predictive ability [C-statistic, integrated discrimination improvement (IDI), and net reclassification improvement (NRI)]. We replicated models in two independent European cohorts: Age, Gene/Environment Susceptibility Reykjavik Study (AGES), n = 4467; Rotterdam Study (RS), n = 3203. B-type natriuretic peptide and CRP were significantly associated with AF incidence (n = 1186): hazard ratio per 1-SD ln-transformed biomarker 1.66 [95% confidence interval (CI), 1.56-1.76], P < 0.0001 and 1.18 (95% CI, 1.11-1.25), P < 0.0001, respectively. Model calibration was sufficient (BNP, χ(2) = 17.0; CRP, χ(2) = 10.5; BNP and CRP, χ(2) = 13.1). B-type natriuretic peptide improved the C-statistic from 0.765 to 0.790, yielded an IDI of 0.027 (95% CI, 0.022-0.032), a relative IDI of 41.5%, and a continuous NRI of 0.389 (95% CI, 0.322-0.455). The predictive ability of CRP was limited (C-statistic increment 0.003). B-type natriuretic peptide consistently improved prediction in AGES and RS. CONCLUSION: B-type natriuretic peptide, not CRP, substantially improved AF risk prediction beyond clinical factors in an independently replicated, heterogeneous population. B-type natriuretic peptide may serve as a benchmark to evaluate novel putative AF risk biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/europace/euu175

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 173

Metadata

Authors
Sinner, M. F., Stepas, K. A., Moser, C. B., Krijthe, B. P., Aspelund, T., Sotoodehnia, N., Fontes, J. D., Janssens, A. C. J. W., Kronmal, R. A., Magnani, J. W., Witteman, J. C., Chamberlain, A. M., Lubitz, S. A., Schnabel, R. B., Vasan, R. S., Wang, T. J., Agarwal, S. K., McManus, D. D., Franco, O. H., Yin, X., Larson, M. G., Burke, G. L., Launer, L. J., Hofman, A., Levy, D., Gottdiener, J. S., Kääb, S., Couper, D., Harris, T. B., Astor, B. C., Ballantyne, C. M., Hoogeveen, R. C., Arai, A. E., Soliman, E. Z., Ellinor, P. T., Stricker, B. H. C., Gudnason, V., Heckbert, S. R., Pencina, M. J., Benjamin, E. J., & Alonso, A.
Venue
EP Europace
Published
2014-07-18
Volume
16
Issue
10
Pages
1426-1433
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W2120722598
Cited by
173
References
9
FWCI
10.11
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. https://app.cochat.ai/papers/10.1093/europace/euu175
The paper
Sinner, M. F., Stepas, K. A., Moser, C. B., Krijthe, B. P., Aspelund, T., Sotoodehnia, N., Fontes, J. D., Janssens, A. C. J. W., Kronmal, R. A., Magnani, J. W., Witteman, J. C., Chamberlain, A. M., Lubitz, S. A., Schnabel, R. B., Vasan, R. S., Wang, T. J., Agarwal, S. K., McManus, D. D., Franco, O. H., . . . Alonso, A. (2014). B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. EP Europace. https://doi.org/10.1093/europace/euu175

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.